Across TCGA pan-cancer cohorts, IGLC7 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IGLC7 data layer compared with 19 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher IGLC7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IGLC7 expression acts as an unfavorable survival marker.

UCEC and ESCA are the cancer types where IGLC7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: IGLC7 tumor-vs-normal RNA expression · all IGLC7 data types